LLY

1,028

-1.37%↓

JNJ

245.17

-0.42%↓

ABBV

226.93

-0.59%↓

NVS

166.41

-0.16%↓

MRK

122.41

-1.23%↓

LLY

1,028

-1.37%↓

JNJ

245.17

-0.42%↓

ABBV

226.93

-0.59%↓

NVS

166.41

-0.16%↓

MRK

122.41

-1.23%↓

LLY

1,028

-1.37%↓

JNJ

245.17

-0.42%↓

ABBV

226.93

-0.59%↓

NVS

166.41

-0.16%↓

MRK

122.41

-1.23%↓

LLY

1,028

-1.37%↓

JNJ

245.17

-0.42%↓

ABBV

226.93

-0.59%↓

NVS

166.41

-0.16%↓

MRK

122.41

-1.23%↓

LLY

1,028

-1.37%↓

JNJ

245.17

-0.42%↓

ABBV

226.93

-0.59%↓

NVS

166.41

-0.16%↓

MRK

122.41

-1.23%↓

Search

McKesson Corp

Geschlossen

BrancheGesundheitswesen

960 0.36

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

949.38

Max

965.06

Schlüsselkennzahlen

By Trading Economics

Einkommen

40M

1.3B

Verkäufe

3B

106B

KGV

Branchendurchschnitt

27.395

108.767

Dividendenrendite

0.32

Gewinnspanne

1.177

Angestellte

43,000

EBITDA

374M

1.8B

Empfehlungen

By TipRanks

Empfehlungen

Starkes Kaufsignal

12-Monats-Prognose

+2.79% upside

Dividenden

By Dow Jones

Dividendenrendite

Branchendurchschnitt

0.32%

2.21%

Nächstes Ergebnis

7. Mai 2026

Nächste Dividendenausschüttung

1. Apr. 2026

Nächstes Ex-Dividendendatum

2. März 2026

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

12B

117B

Vorheriger Eröffnungskurs

959.64

Vorheriger Schlusskurs

960

Nachrichtenstimmung

By Acuity

59%

41%

302 / 351 Ranking in Healthcare

Technischer Score

By Trading Central

Vertrauen

Strong Bearish Evidence

McKesson Corp Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

25. Feb. 2026, 23:25 UTC

Heiße Aktien

Stocks to Watch: C3.ai, Salesforce, Pure Storage, Zoom

25. Feb. 2026, 23:15 UTC

Ergebnisse

Salesforce Sees Stable Growth; CEO Dismisses Talk of AI-Fueled 'SaaS-Pocalypse' -- 2nd Update

25. Feb. 2026, 23:54 UTC

Market Talk

Gold Steady Ahead of U.S.-Iran Talks -- Market Talk

25. Feb. 2026, 23:47 UTC

Ergebnisse

Ferrovial 4Q Net EUR197M >FER.MC

25. Feb. 2026, 23:45 UTC

Ergebnisse

Ferrovial 4Q Rev EUR2.72B >FER.MC

25. Feb. 2026, 23:42 UTC

Ergebnisse

Nvidia Beats Back Bubble Fears With Record $68 Billion Sales in Fourth Quarter -- 4th Update

25. Feb. 2026, 23:38 UTC

Market Talk

Nikkei May Rise, Tracking Wall Street's Gains -- Market Talk

25. Feb. 2026, 23:25 UTC

Ergebnisse

Trip.com: Company's Business Operations Remain Normal >TCOM

25. Feb. 2026, 23:25 UTC

Ergebnisse

Trip.com Gives Update on Investigation by China's State Administration for Market Regulation >TCOM

25. Feb. 2026, 23:25 UTC

Ergebnisse

Trip.com: Cannot Predict Status or Results of Investigation, Will Provide Updates on Conclusion >TCOM

25. Feb. 2026, 23:25 UTC

Ergebnisse

Trip.com Increase in FY Profit Primarily Due to Gain From Investments >TCOM

25. Feb. 2026, 23:25 UTC

Ergebnisse

Trip.com Will Continue to Communicate With SAMR on Compliance With Regulatory Requirements >TCOM

25. Feb. 2026, 23:25 UTC

Ergebnisse

Trip.com: SAMR Investigation Related to China's Anti-monopoly Law >TCOM

25. Feb. 2026, 23:25 UTC

Ergebnisse

Trip.com: Investigation Ongoing, Company Is Cooperating With SAMR >TCOM

25. Feb. 2026, 23:25 UTC

Ergebnisse

Trip.com Co-founders Min Fan, Qi Ji Resign From Positions >TCOM

25. Feb. 2026, 23:25 UTC

Ergebnisse

Trip.com: Fan Resigned as Director and President; Ji Resigned as a Director >TCOM

25. Feb. 2026, 23:25 UTC

Ergebnisse

Trip.com FY Rev CNY62.4B, Up 17% >TCOM

25. Feb. 2026, 23:25 UTC

Ergebnisse

Trip.com FY Net CNY33.3B Vs. Net CNY17.1B >TCOM

25. Feb. 2026, 23:25 UTC

Ergebnisse

Trip.com FY EPS CNY47.67 >TCOM

25. Feb. 2026, 23:06 UTC

Ergebnisse

Correction to Nvidia Fourth Quarter Results Article -- WSJ

25. Feb. 2026, 23:01 UTC

Ergebnisse

Nvidia Beats Back Bubble Fears With Record $68 Billion Sales in Fourth Quarter -- 3rd Update

25. Feb. 2026, 23:00 UTC

Market Talk
Ergebnisse

Global Equities Roundup: Market Talk

25. Feb. 2026, 23:00 UTC

Market Talk
Ergebnisse

Nvidia: Chinese Competitors Pose Risk to U.S. Dominance in AI -- Market Talk

25. Feb. 2026, 22:56 UTC

Market Talk
Ergebnisse

Nvidia CEO Says Customers Can't Grow Revenue Without Compute -- Market Talk

25. Feb. 2026, 22:43 UTC

Ergebnisse
Akquisitionen, Fusionen, Übernahmen

Paramount Streaming Revenue Rises, but TV Segment Faces Headwinds -- WSJ

25. Feb. 2026, 22:40 UTC

Market Talk
Ergebnisse

Nvidia Says Agentic AI Has Reached Inflection Point -- Market Talk

25. Feb. 2026, 22:40 UTC

Ergebnisse

Karoon Energy Says Search for New CFO Well Advanced

25. Feb. 2026, 22:39 UTC

Ergebnisse

Karoon Energy Says CFO Ray Church to Leave Company

25. Feb. 2026, 22:39 UTC

Ergebnisse

Karoon Energy Says On-Market Share Buyback Program Ongoing at Moderated Level

25. Feb. 2026, 22:38 UTC

Ergebnisse

Karoon Energy Says Guidance for 2026 Key Metrics Unchanged

Peer-Vergleich

Kursveränderung

McKesson Corp Prognose

Kursziel

By TipRanks

2.79% Vorteil

12-Monats-Prognose

Durchschnitt 990.1 USD  2.79%

Hoch 1,107 USD

Tief 885 USD

Basierend auf 11 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für McKesson Corp – Dist angeboten haben.

Rating-Konsens

By TipRanks

Starkes Kaufsignal

11 ratings

9

Buy

2

Halten

0

Sell

Technischer Score

By Trading Central

681.92 / 707.28Unterstützung & Widerstand

Kurzfristig

Strong Bearish Evidence

Mittelfristig

No Evidence

Langfristig

No Evidence

Stimmung

By Acuity

302 / 351 Ranking in Gesundheitswesen

Nachrichtenstimmung

Bärische Evidenz

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Unterdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über McKesson Corp

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The RxTS segment serves biopharma and life sciences partners, and patients to address medication challenges for patients by working across healthcare; connects patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies to deliver innovative solutions to help people get the medicine needed to live healthier lives; and provides prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support services. The Medical-Surgical Solutions segment offers medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. The International segment provides distribution and services to wholesale, institutional, and retail customers in Europe and Canada. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
help-icon Live chat